The University of Texas M. D. Anderson Cancer Center has joined the U.S.-Middle East Partnership for Breast Cancer Awareness and Research, a collaboration designed to increase early breast cancer detection and reduce related deaths in the region through improved awareness, increased clinical resources and world-class research.
Findings of a new Mayo Clinic study published this week in Archives of Internal Medicine show that a computerized mail and phone reminder program can significantly increase the percentage of patients receiving preventive health services and improve the value of health care.
So-called ?triple negative? breast cancers, tumors that do not contain any of three significant tumor markers, are aggressive, deadly cancers that affect young, poor minority women, according to a new study.
Harvard Medical School researchers are working on a new, simpler way to distinguish malignant tumors from non-cancerous masses when screening for breast cancer.
Herceptin receives positive opinion in Europe for use in combination with an aromatase inhibitor for the treatment of patients with HER2- and hormone receptor-positive metastatic breast cancer.
Researchers have found that postmenopausal women whose diet contains high amounts of lignans, estrogen-like chemical compounds found in plants, may have a reduced risk of breast cancer.
Eating a high-fat diet may lead to an increased risk of invasive breast cancer in postmenopausal women.
Postmenopausal women whose diet contains high amounts of lignans, estrogen-like chemical compounds found in plants, may have a reduced risk of breast cancer.
The US Food and Drug Administration (FDA) approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
The Canadian Practice Guidelines for the Care and Treatment of Breast Cancer, first published in 1998, were developed to reduce variation in the way that breast cancer was being treated.